Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | CR6086 |
Synonyms | |
Therapy Description |
CR6086 is an antagonist of the prostaglandin E2 receptor 4 (EP4) with potential immunomodulatory activity, and may enhance inhibition of tumor growth (PMID: 29490676;Cancer Res 2020;80(16 Suppl):Abstract nr 2208). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
CR6086 | CR 6086|CR-6086 | CR6086 is an antagonist of the prostaglandin E2 receptor 4 (EP4) with potential immunomodulatory activity, and may enhance inhibition of tumor growth (PMID: 29490676;Cancer Res 2020;80(16 Suppl):Abstract nr 2208). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|